2013
DOI: 10.1016/j.neuro.2013.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Non-dioxin-like PCBs inhibit [3H]WIN-35,428 binding to the dopamine transporter: A structure–activity relationship study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(22 citation statements)
references
References 43 publications
1
21
0
Order By: Relevance
“…In addition to Σ PCBs, we also assessed interaction by the sum of 12 PCB congeners with anti-estrogenic/dioxin-like properties (i.e., IUPAC #s 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169 and 189 (Cooke et al, 2001, Van den Berg et al, 2006, Wolff et al, 1997)), the sum of seven PCB congeners with estrogenic properties in vivo or in vitro (i.e., IUPAC #s 52, 77, 95, 99, 101, 110 and 153 (Cooke et al, 2001)), the sum of thyroid active congeners likely to compete for binding to serum TBPs (i.e., IUPAC #s 28, 52, 60, 74, 77, 95, 99, 101, 105, 114, 118, and 126 (Bloom et al, 2014; Chauhan et al, 2000)), and the sum of non-dioxin-like/ortho- PCB congeners that may inhibit dopamine transporter (i.e., IUPAC #s 28, 52, 74, 99, 101, 110, 118, 138, 153, and 180 (Wigestrand et al, 2013)). We reported individual and joint effects for models with p-value (p) < significant product terms (Knol et al, 2009).…”
Section: Methodsmentioning
confidence: 99%
“…In addition to Σ PCBs, we also assessed interaction by the sum of 12 PCB congeners with anti-estrogenic/dioxin-like properties (i.e., IUPAC #s 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169 and 189 (Cooke et al, 2001, Van den Berg et al, 2006, Wolff et al, 1997)), the sum of seven PCB congeners with estrogenic properties in vivo or in vitro (i.e., IUPAC #s 52, 77, 95, 99, 101, 110 and 153 (Cooke et al, 2001)), the sum of thyroid active congeners likely to compete for binding to serum TBPs (i.e., IUPAC #s 28, 52, 60, 74, 77, 95, 99, 101, 105, 114, 118, and 126 (Bloom et al, 2014; Chauhan et al, 2000)), and the sum of non-dioxin-like/ortho- PCB congeners that may inhibit dopamine transporter (i.e., IUPAC #s 28, 52, 74, 99, 101, 110, 118, 138, 153, and 180 (Wigestrand et al, 2013)). We reported individual and joint effects for models with p-value (p) < significant product terms (Knol et al, 2009).…”
Section: Methodsmentioning
confidence: 99%
“…Significant hyperactivity and increased general arousal has been reported in Drosophila administered methamphetamine, a dopamine transporter inhibitor, and in fmn , a Drosophila dopamine transporter mutant (Andretic et al 2005; Kume et al 2005). Given that PCBs, including those present in Aroclor 1254, inhibit the mammalian dopamine transporter (Wigestrand et al 2013), it is possible that Aroclor 1254 could also block dopamine reuptake in the honeybee. An increase in dopaminergic transmission is consistent with hyperactivity in vertebrates and in invertebrates (Andretic et al 2005; Puhl and Mesce 2008; Sawin et al 2000; Zhuang et al 2001).…”
Section: Discussionmentioning
confidence: 99%
“…These effects could be the result of PCB-induced disruptions in synthesis [90], reuptake of DA from the synapse via dopamine transporter (DAT) competitive inhibition [91,92], or packaging of DA into vesicles by vesicular monoamine transporter [93]. More recent studies support the striatal findings, as PCB 180 increased basal extracellular DA in ventral striatum in male and female adult rats [67], and NDL PCBs inhibited DAT binding in male rat synaptosomes in vitro [87, 94]. Adult exposure to A1254 also reduced TH and DAT levels in the striatum in male mice [95].…”
Section: Effects Of Developmental Pcb Exposure On Social Behavior Andmentioning
confidence: 99%